Remote Monitored Systems update on the Pharm2Farm anti-viral mask project

Remote Monitored Systems plc (LON:RMS) has noted the following announcement published by Braveheart Investment Group in respect of Pharm 2 Farm Limited. As announced on 21 August 2020, RMS has signed a binding Share Purchase Agreement for the acquisition of 100% of the share capital of P2F. Completion of the Acquisition remains subject to regulatory and RMS shareholder approval. The full text of the Braveheart announcement is set out below.

Update on the Pharm2Farm anti-viral mask project

Braveheart Investment Group (LON:BRH) has announced that Pharm 2 Farm Limited has placed an order for an automated face mask production line which is expected to be delivered in November 2020 and commissioned by the end of December 2020.

The face mask production line, which is manufactured in Europe, has the capacity to produce up to five million standard or anti-viral face masks per month.

Conventional surgical type masks typically comprise of three layers, with the inner layer acting as a physical barrier to viruses and bacteria. However, they are only recommended for up to two hours of continual use as this layer can become moist and fail, thereby allowing the virus to penetrate though. P2F has developed a second defensive layer that incorporates its own nanotechnology, which is engineered to kill viruses and bacteria. Combining this new active layer with the physical barrier layer, to produce four layer (ply) masks, is expected to improve user safety over a prolonged use.  This new material is currently undergoing testing, specifically, with respect to the time taken to kill viruses, including COVID-19. These tests are, being undertaken at the University of Nottingham and results are expected by the beginning of October. Following a satisfactory outcome of the tests undertaken at the University of Nottingham, it is envisaged that manufacture of the anti-viral face masks will commence in the first quarter of 2021. In the event that these tests do not provide a satisfactory outcome, the production line will be used to produce conventional surgical type masks, which P2F believe could still be produced on a profitable basis.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
Remote Monitored Systems Plc

More articles like this

Masks are still king in combating new COVID strains

New variants of the coronavirus are circulating in King County, but health experts say the same measures that have proven effective in stopping the virus so far should continue to offer protection. The global pandemic took

What is required to use a remote monitoring system?

Most remote monitoring systems require an internet or WiFi connection and access to an electrical outlet to power them. If you don’t have an internet connection at your location, you’ll want to choose a cellular system.

Remote Monitored Systems General Meeting link for webinar

Remote Monitored Systems plc (LON:RMS) has announced the details for shareholders wishing to view today’s general meeting, to be held at 1.00pm. In view of the UK Government placing restrictions on travel because of Coronavirus (Covid-19),

Pharm2Farm’s antiviral mask: How does it work?

Instead of the usual three-ply design, the five-ply surgical mask includes an additional antiviral inner layer which incorporates nano-copper created using a patented process developed at the university. The copper, which is embedded into the mask

Next generation shaft monitoring

Advanced Remote Monitoring GyroMetric systems can be configured to send data via a communications satellite to data storage in the cloud. This can then be accessed by GyroMetric who can analyse the performance data and provide

Remote Monitored Systems GM to held on 12 February 2021

Remote Monitored Systems plc (LON:RMS) has noted that a shareholder circular convening a general meeting of the Company has been posted to shareholders and will shortly be available on the Company’s website at: www.remotemonitoredsystems.com.  The Company is

RMS’s Pharm2Farm mask now been certified

Shares in Remote Monitored Systems surged by over 10 percent this afternoon following news that its Pharm 2 Farm mask has now been certified as meeting the required bicompatibility test. The mask now has achieved the

Scientists develop facemask which can kill viruses on contact

A new antiviral facemask which uses nanotechnology to kill viruses including COVID-19 and influenza has been designed and developed by a Nottingham Trent University scientist. Instead of the usual three-ply design, the five-ply surgical mask includes

Global security improvement programme

Cloudveil was the appointed consultancy for the Global Security Improvement Programme for the worlds leading integrated steel and mining company. Working with a variety of stakeholders towards improving the maturity of the Global Security Function. Following a review of the Global Security

Pioneering nano technology

Technology initially developed for the medical industry has been optimised for plant and animal nutrition. A number of trials have shown increased nutritional content through fortification, shelf life, increased nutrient use and a lower environmental footprint.